A combined microinvasive trans-submandibular and nasendoscopy surgical approach to dissect recurrent or radiotherapy-insensitive nasopharyngeal carcinoma
暂无分享,去创建一个
Luo Zhang | M. Lian | Jugao Fang | Hongzhi Ma | Ling Feng | Ru Wang | Yan-ming Zhao | Q. Zhong | Jiaming Chen | Shi-zhi He | L. Hou | X. Shen | Yifan Yang | Q. Shi | Jiamin Zhang | Cheng-lin Wang
[1] M. Chua,et al. Retreatment in locally recurrent nasopharyngeal carcinoma: Current status and perspectives , 2021, Cancer communications.
[2] Y. Si,et al. Efficacy and Safety of Endoscopic Nasopharyngectomy Combined With Low-Dose Radiotherapy for Primary T1-2 Nasopharyngeal Carcinoma , 2021, Technology in cancer research & treatment.
[3] W. Wen,et al. Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial. , 2021, The Lancet. Oncology.
[4] Jiazhang Wei,et al. Effects of Surgery Combined with Chemoradiotherapy on Short- and Long-Term Outcomes of Early-Stage Nasopharyngeal Carcinoma , 2020, Cancer management and research.
[5] Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.
[6] Hongmeng Yu,et al. Outcomes of recurrent nasopharyngeal carcinoma patients treated with endoscopic nasopharyngectomy: a meta‐analysis , 2020, International forum of allergy & rhinology.
[7] H. Harada,et al. Management of retropharyngeal lymph node metastasis in oral cancer. , 2019, Oral oncology.
[8] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[9] J. Chan. Surgical management of recurrent nasopharyngeal carcinoma. , 2014, Oral oncology.
[10] S. Billan,et al. Outcome of Patients Undergoing Salvage Surgery for Recurrent Nasopharyngeal Carcinoma: A Meta-analysis , 2014, Annals of Surgical Oncology.
[11] I. Tan,et al. Current Treatment Options for Local Residual Nasopharyngeal Carcinoma , 2013, Current Treatment Options in Oncology.
[12] W. Fee,et al. Nasopharyngeal carcinoma: salvage of local recurrence. , 2012, Oral oncology.
[13] Y. Chan,et al. Quality of life of patients after salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma , 2012, Cancer.
[14] Primož Strojan,et al. Retropharyngeal lymph node metastases in head and neck malignancies , 2011, Head & neck.
[15] F. Schmidt. Meta-Analysis , 2008 .
[16] S. Lo,et al. Treatment results of 1070 patients with nasopharyngeal carcinoma: An analysis of survival and failure patterns , 2005, Head & neck.
[17] S. Leung,et al. Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. , 2005, International journal of radiation oncology, biology, physics.
[18] W. Wei,et al. Nasopharyngeal cancer: current status of management: a New York Head and Neck Society lecture. , 2001, Archives of otolaryngology--head & neck surgery.
[19] T. Lam,et al. Salvage of Local Recurrence , 2019, Nasopharyngeal Carcinoma.
[20] F. Chan. THE HONG KONG EXPERIENCE , 1995 .